2Gelfand EW, Appajosyula S, Meeves S. Anti- inflammatory activiy of H1- R receptor antagonists:review of recent experimental research[J]. Curr Mcd Res Opin, 2004,20 : 73- 81.
3Kawashima M, Harada S,Tango T. Review of fexofenadine in the treatment of chronic idiopathicurticaria[J]. Int J Dermatol, 2002, 4:701--781.
4RingJ, HeinR, Gauger A, et al. Once- R daily desloratadine improves the signs and symptoms of Chronic idiopathic urticaria: arandomized,double-R blind, placebo- R controlled study[J]. Int J Dematol,2001,40:72-76.
5Valk P J, Van Roon DB, Simons R M, et al. Des loratadine shows no effect on performance during 6h at 8,000 fi simulated cabin ahitude[J]. Aviat Space Environ Med, 2004,75:433--438.
6Henz BM. The pharmacologic profile of desloratadine: a review [J]. Alergy, 2001,56(Suppl 65) : 7-- 13.
7Di Lorenzo G, Pacor ML, Mansueto P, et al. Randomized placebo -R controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therpy for chronic idiopathic urticaria[J]. J Allergy Clin Immunol, 2001,14:619--625.
8Erbagci Z. The leukotriene recepto antagonist montelukast in the treatment of Chronic idiopathic urticaria: a single-R blind,placeb -Re ontrolled,crossover clinical study[J]. J Allergy Clin Immunol ,2002,110:484--488.
9Loria MP, Dambra PP, D'Oronzio L, et al. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative Immunopharmacol[- J]. Immunotoxicol, 2001,23 : 205 -- 213.
10askan EB, Tunali S, Turker T, et al. Comparison of short- R and long-R term cyclosporine A therapy in chronic idiopathic urticaria[J]. J Dermatolog Treat, 2004,15 : 164-- 168.
